Colrain Capital LLC Gilead Sciences, Inc. Transaction History

Colrain Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $1.29 Million - $1.45 Million	-20,680 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$71.28 - $78.92 $285,120 - $315,680	-4,000 Reduced 16.21%	20,680 $1.6 Million
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $315,965 - $368,561	-4,870 Reduced 16.48%	24,680 $1.75 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $413,731 - $504,384	-5,680 Reduced 16.12%	29,550 $2.23 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $3.35 Million - $3.93 Million	-47,108 Reduced 57.21%	35,230 $2.52 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $5.94 Million - $7.04 Million	82,338	82,338 $6.67 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Colrain Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Colrain Capital LLC with notifications on news.